<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=BioViva</id>
	<title>BioViva - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=BioViva"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=BioViva&amp;action=history"/>
	<updated>2026-06-09T16:00:06Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=BioViva&amp;diff=8779&amp;oldid=prev</id>
		<title>Rodion: Новая страница: «right &#039;&#039;&#039;BioViva&#039;&#039;&#039; is a Seattle based biotech company working on treatments to slow the ageing process in humans.  == History == In September 2015, CEO Liz Parrish flew to Colombia to receive two experimental gene therapies. One was a myostatin inhibitor, a drug that is being tested as a treatment for muscle loss. The other was a telomerase gene therapy, the drug that BioViva clai...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=BioViva&amp;diff=8779&amp;oldid=prev"/>
		<updated>2023-01-15T06:27:18Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «&lt;a href=&quot;/%D0%A4%D0%B0%D0%B9%D0%BB:BioViva-logosmall.png&quot; title=&quot;Файл:BioViva-logosmall.png&quot;&gt;thumb|right&lt;/a&gt; &amp;#039;&amp;#039;&amp;#039;BioViva&amp;#039;&amp;#039;&amp;#039; is a Seattle based &lt;a href=&quot;/index.php?title=Biotechnology&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Biotechnology (страница не существует)&quot;&gt;biotech&lt;/a&gt; company working on treatments to slow the &lt;a href=&quot;/Senescence&quot; class=&quot;mw-redirect&quot; title=&quot;Senescence&quot;&gt;ageing process&lt;/a&gt; in humans.  == History == In September 2015, CEO &lt;a href=&quot;/Liz_Parrish&quot; title=&quot;Liz Parrish&quot;&gt;Liz Parrish&lt;/a&gt; flew to Colombia to receive two experimental gene therapies. One was a myostatin inhibitor, a drug that is being tested as a treatment for muscle loss. The other was a telomerase &lt;a href=&quot;/index.php?title=Gene_therapy&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Gene therapy (страница не существует)&quot;&gt;gene therapy&lt;/a&gt;, the drug that BioViva clai...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:BioViva-logosmall.png|thumb|right]]&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;BioViva&amp;#039;&amp;#039;&amp;#039; is a Seattle based [[biotechnology|biotech]] company working on treatments to slow the [[Senescence|ageing process]] in humans.&lt;br /&gt;
&lt;br /&gt;
== History ==&lt;br /&gt;
In September 2015, CEO [[Liz Parrish]] flew to Colombia to receive two experimental gene therapies. One was a myostatin inhibitor, a drug that is being tested as a treatment for muscle loss. The other was a telomerase [[gene therapy]], the drug that BioViva claims has reversed her cells&amp;#039; biological age, by lengthening parts of her genetic material called [[telomere]]s.&amp;lt;ref name=&amp;quot;guardian&amp;quot;&amp;gt;[https://www.theguardian.com/science/2016/jul/24/elizabeth-parrish-gene-therapy-ageing Can this woman cure ageing with gene therapy?]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
If early data is accurate, it is the world&amp;#039;s first successful example of telomere lengthening via gene therapy in a human individual.&amp;lt;ref&amp;gt;[http://www.dailymail.co.uk/sciencetech/article-3559947/Could-gene-therapy-help-live-forever-CEO-controversial-firm-claims-successfully-carried-anti-ageing-treatment-herself.html Could gene therapy help you live forever? CEO of controversial firm claims she has successfully carried out first anti-ageing treatment - on herself]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation is owned by umbrella company [[BioTrove Investments]].&lt;br /&gt;
&lt;br /&gt;
== Controversy ==&lt;br /&gt;
The treatment as well as the [[self-experimentation]] is highly controversial. Because the necessary pre-clinical work to progress to human studies, the US [[Food and Drug Administration]] did not authorise Parrish&amp;#039;s experiment, requiring her to travel for treatment.&lt;br /&gt;
&lt;br /&gt;
Timothy Caulfield, professor in the Faculty of Law and the School of Public Health at the University of Alberta characterising BioViva&amp;#039;s work as &amp;#039;[[Pseudo-science]]&amp;#039; and lacking scientific rigour. George M Martin, professor of pathology at the University of Washington had agreed to be an adviser to the company but resigned on hearing about the self-experiment.&amp;lt;ref name=&amp;quot;guardian&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== External links ==&lt;br /&gt;
* [http://bioviva-science.com/ bioviva-science.com]&lt;br /&gt;
* [https://www.youtube.com/channel/UCaBq8hEExcUN6mtKMEuBvMQ YouTube channel]&lt;br /&gt;
* {{Wikipedia|BioViva}}&lt;br /&gt;
* {{twitter|BiovivaUsa}}&lt;br /&gt;
{{facebook page|https://www.facebook.com/BiovivaSciences/}}&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
[[Category:Transhumanist organisations]]&lt;br /&gt;
[[Category:American organisations]]&lt;br /&gt;
[[Category:YouTube]]&lt;/div&gt;</summary>
		<author><name>Rodion</name></author>
	</entry>
</feed>